Pharmacogenetic Trial and Long-term Follow-up of the PRISMS Trial (PRISMS-15)
NCT01034644
·
clinicaltrials.gov ↗
COMPLETED
Status
290
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Sclerosis
Sponsor
Merck KGaA, Darmstadt, Germany